Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
A study testing duvakitug for patients with moderately to severely active ulcerative colitis
AustriaA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
CzechiaStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
AustriaLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
AustriaStudy of VENT-03 tablets in adults with active cutaneous lupus erythematosus with or without systemic lupus erythematosus
BulgariaLong-term safety and effectiveness study of APG777 injection in patients with moderate-to-severe atopic dermatitis who previously received APG777 treatment
CzechiaStudy of early versus late risankizumab treatment to evaluate immune cell response in patients with moderate to severe psoriasis
SpainStudy of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial
GermanyStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
AustriaTesting SAR442970 compared to placebo in adults with moderate to severe Crohn's disease
BelgiumStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
BelgiumStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
AustriaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
